Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs

Lipoplatin™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer

(2014) A. Ravaioli et al.   JOURNAL OF CHEMOTHERAPY

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

(2011) Ninh M. La-Beck et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

(2011) Eric J. Feldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Research Highlights

(2011) Jonathan F Lovell et al.   Nanomedicine

A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy

(2010) S.R. Paliwal et al.   CURRENT CANCER DRUG TARGETS

Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics

(2010) Jianqiu Wang et al.   CURRENT DRUG METABOLISM

Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer

(2010) Maria Ornella Nicoletto et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death

(2010) Hila Epstein-Barash et al.   JOURNAL OF CONTROLLED RELEASE

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors

(2010) William C. Zamboni et al.   JOURNAL OF LIPOSOME RESEARCH

Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery

(2010) T. D. Tailor et al.   MOLECULAR CANCER THERAPEUTICS

Targeting Liposomes Toward Novel Pediatric Anticancer Therapeutics

(2010) Noah Federman et al.   PEDIATRIC RESEARCH

Release of Liposomal Contents by Cell-Secreted Matrix Metalloproteinase-9

(2009) Jayati Banerjee et al.   BIOCONJUGATE CHEMISTRY

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models

(2009) Alberto Gabizon et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes

(2009) Avi Schroeder et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies

(2009) W. C. Zamboni et al.   CLINICAL CANCER RESEARCH

Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies

(2009) W C Zamboni et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage

(2009) Hilary Shmeeda et al.   JOURNAL OF CONTROLLED RELEASE

Development of a highly stable and targetable nanoliposomal formulation of topotecan

(2009) Daryl C. Drummond et al.   JOURNAL OF CONTROLLED RELEASE

Amphotericin B: side effects and toxicity

(2009) Rafael Laniado-Laborín et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

(2008) H. Maeda et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain

(2008) Vandana Soni et al.   JOURNAL OF DRUG TARGETING

Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development

(2008) Daryl C. Drummond et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics

(2008) Robert B. Campbell et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Pharmacokinetics and Biodistribution of Nanoparticles

(2008) Shyh-Dar Li et al.   MOLECULAR PHARMACEUTICS

Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

(2008) Frank Alexis et al.   MOLECULAR PHARMACEUTICS

Factors affecting toxicity and efficacy of polymeric nanomedicines

(2008) Eiki Igarashi   TOXICOLOGY AND APPLIED PHARMACOLOGY